Aptamer Group

Aptamer Group is a leading provider of Optimer® binders for use in therapeutics, diagnostics, bioprocessing and research. They strive to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer® technology. Optimer^® binders are next-generation aptamer molecules derived from nucleic acids that function as an antibody alternative. Optimer^® binders are engineered to address many of the issues found with alternative affinity molecules, such as antibodies, and offer new, innovative solutions to bioprocessing, diagnostic and pharmaceutical scientists.